Bank of America’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,500
Closed -$3.72M 8097
2023
Q3
$3.72M Buy
+8,500
New +$4.24M ﹤0.01% 3675
2016
Q3
Sell
-6,000
Closed -$557K 7215
2016
Q2
$557K Hold
6,000
﹤0.01% 4588
2016
Q1
$470K Buy
+6,000
New +$432K ﹤0.01% 4642

Other funds holding IDXX

Bank of America's IDXX Position: Q1 2026 in Review

Bank of America increased its Idexx Laboratories (IDXX) stake by 0.14% in Q1 2026, buying an estimated $423K and bringing the position to 488,017 shares worth $274M. The position accounts for 0.02% of the portfolio, ranked #595.

Bank of America first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $799M in Q3 2021. 1,315 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Bank of America held 488,017 shares of Idexx Laboratories worth $274M as of Q1 2026.
  • Bank of America bought 659 Idexx Laboratories shares in Q1 2026, an estimated $423K.
  • Idexx Laboratories made up 0.02% of Bank of America's portfolio in Q1 2026, its #595 holding.
  • Bank of America first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Idexx Laboratories position peaked at $799M in Q3 2021.
  • 1,315 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.